Fig. 2

Time from diagnosis until kidney replacement therapy in the corticosteroid group versus the non-corticosteroid group. In this cohort, the addition of corticosteroid therapy (orange) did not delay the progression to end-stage kidney disease, which was defined as the initiation of kidney replacement therapy, compared with only supportive therapy (purple) (p = 0.98). The dashed line indicates the median survival time. Time = Years after diagnostic kidney biopsy. ESKD = end-stage kidney disease